MEGALLOLINE
Live / Registered — Registered (as of 14 Jan 2025)
What this means for you
Registered since 14 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79390167
- Registration number
- 7646753
- Mark type
- Stylized text
- Filed
- 07 Nov 2023
- Published for opposition
- 26 Nov 2024
- Registered
- 14 Jan 2025
- Attorney of record
- Rebeccah Gan
Goods and services
- Class 001 — Chemicals: Stem cells for research; stem cells for scientific purposes; nutrition agents, namely, cell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical and veterinary purposes
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns, spinal cord injuries, Huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, functional microtissues that facilitate transplantation and graft integration; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns, spinal cord injuries, Huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, functional microtissues that facilitate transplantation and graft integration; stem cells for medical or veterinary use; pluripotent stem cells for medical use intended for cell and gene therapies; cultures of cell media for medical and veterinary use; surgical implants comprised of living tissues obtained from stem cells
- Class 042 — Scientific and technological services: Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology
Owner
Prosecution history
- 14 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2024 — REFUSAL PROCESSED BY IB
- 28 Jun 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 28 Jun 2024 — REFUSAL PROCESSED BY MPU
- 16 Jun 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 15 Jun 2024 — NON-FINAL ACTION WRITTEN
- 15 Jun 2024 — ASSIGNED TO EXAMINER